Flashcards on Medical Ethics: Charlie Gard Case Study
Medical Ethics: Charlie Gard Case Study Analysis for Students
Tap to flip · Swipe to navigate
Clinical ethics and experimental treatment
12 cards
Card 1
Question: In the Charlie Gard case, who were the main parties involved in deciding the child's medical fate?
Answer: The parents (seeking experimental treatment) and the treating doctors (Great Ormond Street Hospital), with the state/courts ultimately involved in dec
Card 2
Question: What is a key role of clinical ethics and mediation in conflicts over experimental treatment?
Answer: To mediate between parents and doctors, helping resolve disputes about treatment decisions and values.
Card 3
Question: How should medical futility be assessed according to the content?
Answer: By weighing benefits and risks of treatment in relation to the patient's clinical condition, while recognizing a subjective/value-judgement dimension
Card 4
Question: What caution is given about using 'quality of life' when deciding to discontinue treatment?
Answer: Discontinuing treatment should not imply that a particular form of being is worse than non-being; 'quality of life' should not be used as a reason for
Card 5
Question: How can social media and large-group involvement affect clinical decisions in high-profile experimental treatment cases?
Answer: They can put additional pressure on health professionals.
Card 6
Question: What ethical tensions are highlighted by requests for experimental or unproven therapies?
Answer: Tensions between parental autonomy, medical paternalism, defensive medicine, futile treatment, and the desire for cure or experimentation.
Card 7
Question: What distinction related to end-of-life care is emphasized in clinical ethics for experimental treatment?
Answer: The difference between passive euthanasia and withdrawing or not providing futile treatment; withdrawing futile treatment is ethically different from
Card 8
Question: What institutional or systemic consideration is relevant to decisions about experimental treatment?
Answer: Healthcare system models and distributive justice — how resources and access to treatments are allocated.
Card 9
Question: What should analysis of cases involving experimental treatment include regarding professional roles?
Answer: Consideration of models of the doctor–patient relationship and the role of the clinical ethicist in mediation.
Card 10
Question: What rules or frameworks should be considered when evaluating experimental therapy requests?
Answer: Rules for preclinical and clinical testing of medicinal products and for experimental therapy (e.g., evidence levels, prior animal data, clinical tria